Oral hypoglycemic agents? Negative.
I am convinced that oral hypoglycemic therapy is associated with increased cardiovascular mortality. But the more important issue is whether the benefits of these agents are worth the risk.
Chalmers
T C
TC
Harvard School of Public Health, Veterans Affairs Medical Center, Boston.
D001291:Attitude of Health Personnel; D015982:Bias; D002318:Cardiovascular Diseases / Q000139:chemically induced / Q000401:mortality*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D010820:Physicians / Q000523:psychology; D012106:Research / Q000592:standards*
D007004:Hypoglycemic Agents; D007328:Insulin